{"id":404364,"date":"2025-06-27T12:00:00","date_gmt":"2025-06-27T10:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/modulation-de-lintegrine-pour-le-controle-des-metastases-dans-le-cancer-de-la-vessie-resistant-au-cisplatine\/"},"modified":"2025-06-30T16:43:38","modified_gmt":"2025-06-30T14:43:38","slug":"modulation-de-lintegrine-pour-le-controle-des-metastases-dans-le-cancer-de-la-vessie-resistant-au-cisplatine","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/modulation-de-lintegrine-pour-le-controle-des-metastases-dans-le-cancer-de-la-vessie-resistant-au-cisplatine\/","title":{"rendered":"Modulation de l&#8217;int\u00e9grine pour le contr\u00f4le des m\u00e9tastases dans le cancer de la vessie r\u00e9sistant au cisplatine"},"content":{"rendered":"\n<p><strong>Le carcinome uroth\u00e9lial de la vessie est un exemple parfait du conflit clinique entre les progr\u00e8s th\u00e9rapeutiques et la r\u00e9sistance biologique. Alors que les tumeurs superficielles peuvent souvent \u00eatre r\u00e9s\u00e9qu\u00e9es avec succ\u00e8s ou contr\u00f4l\u00e9es par des th\u00e9rapies intrav\u00e9sicales, le parcours des tumeurs m\u00e9tastatiques ou invasives au niveau musculaire est souvent fatal. L&#8217;un des plus grands d\u00e9fis : la r\u00e9sistance cellulaire aux chimioth\u00e9rapies \u00e0 base de platine &#8211; en particulier le cisplatine, consid\u00e9r\u00e9 jusqu&#8217;\u00e0 pr\u00e9sent comme l&#8217;\u00e9talon-or dans le traitement syst\u00e9mique.  <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fmodulation-de-lintegrine-pour-le-controle-des-metastases-dans-le-cancer-de-la-vessie-resistant-au-cisplatine%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Le carcinome uroth\u00e9lial de la vessie est un exemple parfait du conflit clinique entre les progr\u00e8s th\u00e9rapeutiques et la r\u00e9sistance biologique. Alors que les tumeurs superficielles peuvent souvent \u00eatre r\u00e9s\u00e9qu\u00e9es&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fmodulation-de-lintegrine-pour-le-controle-des-metastases-dans-le-cancer-de-la-vessie-resistant-au-cisplatine%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":404366,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"L'art\u00e9sunate en uro-oncologie  ","footnotes":""},"category":[11527,11531,11389,11549,11514],"tags":[83875,17607,17611,83874],"powerkit_post_featured":[],"class_list":["post-404364","post","type-post","status-publish","format-standard","has-post-thumbnail","category-etudes","category-formation-continue","category-oncologie","category-rx-fr","category-urologie-fr","tag-artesunat-fr","tag-cancer-de-la-vessie","tag-carcinome-urothelial","tag-cisplatine","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-05-02 11:33:13","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":{"it_IT":{"locale":"it_IT","id":404358,"slug":"modulazione-dellintegrina-per-il-controllo-delle-metastasi-nel-cancro-della-vescica-resistente-al-cisplatino","post_title":"Modulazione dell'integrina per il controllo delle metastasi nel cancro della vescica resistente al cisplatino","href":"https:\/\/medizinonline.com\/it\/modulazione-dellintegrina-per-il-controllo-delle-metastasi-nel-cancro-della-vescica-resistente-al-cisplatino\/"},"pt_PT":{"locale":"pt_PT","id":404313,"slug":"modulacao-da-integrina-para-o-controlo-de-metastases-no-cancro-da-bexiga-resistente-a-cisplatina","post_title":"Modula\u00e7\u00e3o da integrina para o controlo de met\u00e1stases no cancro da bexiga resistente \u00e0 cisplatina","href":"https:\/\/medizinonline.com\/pt-pt\/modulacao-da-integrina-para-o-controlo-de-metastases-no-cancro-da-bexiga-resistente-a-cisplatina\/"},"es_ES":{"locale":"es_ES","id":404316,"slug":"modulacion-de-las-integrinas-para-el-control-de-las-metastasis-en-el-cancer-de-vejiga-resistente-al-cisplatino","post_title":"Modulaci\u00f3n de las integrinas para el control de las met\u00e1stasis en el c\u00e1ncer de vejiga resistente al cisplatino","href":"https:\/\/medizinonline.com\/es\/modulacion-de-las-integrinas-para-el-control-de-las-metastasis-en-el-cancer-de-vejiga-resistente-al-cisplatino\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/404364","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=404364"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/404364\/revisions"}],"predecessor-version":[{"id":404368,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/404364\/revisions\/404368"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/404366"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=404364"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=404364"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=404364"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=404364"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}